Advancing Oligonucleotide Drug Development

Perfecting the molecular building blocks of oligonucleotides is paramount to developing effective nucleic acid-based therapeutics.

Oligonucleotide therapeutics have emerged as a promising novel class of drugs to treat a wide range of diseases. The development of these therapeutics relies on the proper use of modified molecular building blocks called phosphoramidites to generate high quality oligonucleotides. In this webinar brought to you by Thermo Fisher Scientific, Gary Held will discuss the latest techniques for phosphoramidite synthesis, selection, and evaluation during oligonucleotide drug development. 

Topics to be covered

  • Optimizing phosphoramidites for oligonucleotide therapeutic development and manufacturing
  • Identifying phosphoramidite impurities and their potential impacts on oligonucleotide therapeutics

Thursday, May 18th, 2023 | 10:30 AM - 11:30 AM Eastern Time
This webinar will be available to view live and on demand.


Gary Held, MBA

Gary Held

Staff Scientist, Analytical Development 
Thermo Fisher Scientific 

Sponsored by